Literature DB >> 22177735

Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus.

Alexandros P Grammatikos1, George C Tsokos.   

Abstract

Recent evidence suggests that systemic autoimmunity and immunodeficiency are not separate entities, but rather are interconnected processes. Immunodeficiency results from distinct defects of the immune response and primarily presents as infections but also frequently with autoimmune features. Systemic autoimmunity is the combined effect of multiple genetic variations and infectious and immunoregulatory factors that result in dominant autoimmune manifestations, in addition to frequent and opportunistic infections. The overlap in disease manifestations and symptoms suggests that immunodeficiency should be considered in the presence of autoimmunity, and vice versa. In this review, we present the shared or similar aspects of immunodeficiency and autoimmunity using systemic lupus erythematosus as a paradigm and discuss the implications for clinical care.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22177735      PMCID: PMC3278563          DOI: 10.1016/j.molmed.2011.10.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  88 in total

1.  Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.

Authors:  Xuebing Feng; Hui Wu; Jennifer M Grossman; Punchong Hanvivadhanakul; John D FitzGerald; Grace S Park; Xin Dong; Weiling Chen; Michelle H Kim; Haoling H Weng; Daniel E Furst; Alan Gorn; Maureen McMahon; Mihaela Taylor; Ernest Brahn; Bevra H Hahn; Betty P Tsao
Journal:  Arthritis Rheum       Date:  2006-09

2.  Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  Jérémie Sellam; Corinne Miceli-Richard; Jacques-Eric Gottenberg; Marc Ittah; Frédéric Lavie; Christine Lacabaratz; Nicolas Gestermann; Alexis Proust; Olivier Lambotte; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2006-12-21       Impact factor: 19.103

3.  TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats.

Authors:  Danny Zipris; Egil Lien; Jenny X Xie; Dale L Greiner; John P Mordes; Aldo A Rossini
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

4.  Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naïve mice.

Authors:  A P Kuan; L Zuckier; L Liao; S M Factor; B Diamond
Journal:  Circ Res       Date:  2000-02-18       Impact factor: 17.367

5.  Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus.

Authors:  Hyung-Bae Park; Ki-Chan Kim; Jae-Hong Park; Tae-Young Kang; Hye-Soon Lee; Tae-Hwan Kim; Jae-Bum Jun; Sang-Cheol Bae; Dae-Hyun Yoo; Joe Craft; Sungsoo Jung
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

6.  Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms.

Authors:  Latisha D Heinlen; Micah T McClain; Joan Merrill; Yasmin W Akbarali; Colin C Edgerton; John B Harley; Judith A James
Journal:  Arthritis Rheum       Date:  2007-07

Review 7.  Wiskott-Aldrich syndrome.

Authors:  Luigi D Notarangelo; Carol H Miao; Hans D Ochs
Journal:  Curr Opin Hematol       Date:  2008-01       Impact factor: 3.284

8.  A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice.

Authors:  Hiroyuki Yoshitomi; Noriko Sakaguchi; Katsuya Kobayashi; Gordon D Brown; Tomoyuki Tagami; Toshiko Sakihama; Keiji Hirota; Satoshi Tanaka; Takashi Nomura; Ichiro Miki; Siamon Gordon; Shizuo Akira; Takashi Nakamura; Shimon Sakaguchi
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

9.  TLR3 deficiency in patients with herpes simplex encephalitis.

Authors:  Shen-Ying Zhang; Emmanuelle Jouanguy; Sophie Ugolini; Asma Smahi; Gaëlle Elain; Pedro Romero; David Segal; Vanessa Sancho-Shimizu; Lazaro Lorenzo; Anne Puel; Capucine Picard; Ariane Chapgier; Sabine Plancoulaine; Matthias Titeux; Céline Cognet; Horst von Bernuth; Cheng-Lung Ku; Armanda Casrouge; Xin-Xin Zhang; Luis Barreiro; Joshua Leonard; Claire Hamilton; Pierre Lebon; Bénédicte Héron; Louis Vallée; Lluis Quintana-Murci; Alain Hovnanian; Flore Rozenberg; Eric Vivier; Frédéric Geissmann; Marc Tardieu; Laurent Abel; Jean-Laurent Casanova
Journal:  Science       Date:  2007-09-14       Impact factor: 47.728

10.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.

Authors:  Barbara Serafini; Barbara Rosicarelli; Diego Franciotta; Roberta Magliozzi; Richard Reynolds; Paola Cinque; Laura Andreoni; Pankaj Trivedi; Marco Salvetti; Alberto Faggioni; Francesca Aloisi
Journal:  J Exp Med       Date:  2007-11-05       Impact factor: 14.307

View more
  37 in total

1.  Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiency.

Authors:  Brigid S Boland; Christella E Widjaja; Asoka Banno; Bing Zhang; Stephanie H Kim; Samantha Stoven; Michael R Peterson; Marilyn C Jones; H Irene Su; Sheila E Crowe; Jack D Bui; Samuel B Ho; Yoshinaga Okugawa; Ajay Goel; Eric V Marietta; Mahdieh Khosroheidari; Kristen Jepsen; Jose Aramburu; Cristina López-Rodríguez; William J Sandborn; Joseph A Murray; Olivier Harismendy; John T Chang
Journal:  J Immunol       Date:  2015-02-09       Impact factor: 5.422

2.  Transcription factor Ikaros represses protein phosphatase 2A (PP2A) expression through an intronic binding site.

Authors:  Kamalpreet Nagpal; Katsue Sunahori Watanabe; Betty P Tsao; George C Tsokos
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

3.  Characterization of the Antibody Response after Cervical Spinal Cord Injury.

Authors:  Antigona Ulndreaj; Apostolia Tzekou; Andrea J Mothe; Ahad M Siddiqui; Rachel Dragas; Charles H Tator; Emina E Torlakovic; Michael G Fehlings
Journal:  J Neurotrauma       Date:  2016-12-21       Impact factor: 5.269

4.  Successful anti-TNF-α treatment in a girl with LAD-1 disease and autoimmune manifestations.

Authors:  Manuela Marsili; Vassilios Lougaris; Marta Lucantoni; Daniele Di Marzio; Manuela Baronio; Massimiliano Vitali; Giuliano Lombardi; Francesco Chiarelli; Luciana Breda
Journal:  J Clin Immunol       Date:  2014-08-19       Impact factor: 8.317

5.  A T cell gene expression panel for the diagnosis and monitoring of disease activity in patients with systemic lupus erythematosus.

Authors:  Alexandros P Grammatikos; Vasileios C Kyttaris; Katalin Kis-Toth; Lisa M Fitzgerald; Amy Devlin; Michele D Finnell; George C Tsokos
Journal:  Clin Immunol       Date:  2013-12-16       Impact factor: 3.969

Review 6.  cAMP responsive element modulator: a critical regulator of cytokine production.

Authors:  Thomas Rauen; Christian M Hedrich; Klaus Tenbrock; George C Tsokos
Journal:  Trends Mol Med       Date:  2013-03-13       Impact factor: 11.951

Review 7.  Rheumatologic manifestations of primary immunodeficiency diseases.

Authors:  V R Dimitriades; R Sorensen
Journal:  Clin Rheumatol       Date:  2016-03-14       Impact factor: 2.980

Review 8.  Autoimmunity in immunodeficiency.

Authors:  Krista Todoric; Jessica B Koontz; Daniel Mattox; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

9.  cAMP-responsive element modulator α (CREMα) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE).

Authors:  Thomas Rauen; Alexandros P Grammatikos; Christian M Hedrich; Jürgen Floege; Klaus Tenbrock; Kim Ohl; Vasileios C Kyttaris; George C Tsokos
Journal:  J Biol Chem       Date:  2012-11-02       Impact factor: 5.157

10.  Complement-mediated 'bystander' damage initiates host NLRP3 inflammasome activation.

Authors:  Rahul Suresh; Prabha Chandrasekaran; Fayyaz S Sutterwala; David M Mosser
Journal:  J Cell Sci       Date:  2016-03-22       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.